C2C Wealth Management »

Puma Biotechnology shares owned by C2C Wealth Management

Quarter-by-quarter ownership of Puma Biotechnology (PBYI) shares owned by C2C Wealth Management from 13F filings

Historical chart of C2C Wealth Management investment in Puma Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Puma Biotechnology held by C2C Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Puma Biotechnology by C2C Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $122k 23k 5.31
2025-06-30 $71k 21k 3.43
2025-03-31 $45k 15k 2.96
2024-12-31 $37k 12k 3.05

More positions owned by C2C Wealth Management

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Select Sector Spdr Tr Technology (XLK)
Cohen & Steers infrastucture Fund (UTF)
Chevron Corporation (CVX)
Ishares Tr Russell 2000 Etf (IWM)
International Business Machines (IBM)
Eaton Vance Tax Managed Diversified Eq. (ETY)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Us Aggbd Et (AGG)
Enterprise Products Partners (EPD)
Ishares Tr S&p Mc 400gr Etf (IJK)
Ishares Tr S&p Mc 400vl Etf (IJJ)

View all positions for C2C Wealth Management

Top funds holding Puma Biotechnology

Acorn Capital Advisors
Vanguard Group
BlackRock
Renaissance Technologies
Acadian Asset Management
American Century Companies
Dimensional Fund Advisors
Geode Capital Management
Russell Investments
Connor, Clark & Lunn Investment Management
Kennedy Capital Management
O'shaughnessy Asset Management
State Street Corporation
LSV Asset Management
Marshall Wace

View all funds holding Puma Biotechnology